| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 40,115 | 40,139 | 40,102 | 37,120 | | Cost of Revenue | 13,703 | 13,118 | 12,631 | 12,530 | | | Gross Profit | 26,412 | 27,021 | 27,471 | 24,590 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,691 | 7,335 | 7,543 | 7,518 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 8,151 | 8,182 | 7,783 | 7,307 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,570 | 11,504 | 12,145 | 9,765 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 295 | 411 | (460) | (530) | | Earnings Before Interest And Taxes | 10,865 | 11,915 | 11,685 | 9,235 | | Interest Expense | 193 | 404 | 531 | 227 | | Income Before Tax | 10,672 | 11,511 | 11,154 | 9,008 | | Income Tax Expense | 4,326 | 4,773 | 4,920 | 3,656 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,346 | 6,738 | 6,234 | 5,352 | | | Non-recurring Events | | Discontinued Operations | (39) | (76) | (10,369) | 204 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,307 | 6,662 | (4,135) | 5,556 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,307 | $6,662 | ($4,135) | $5,556 |
|
0.11% Nasdaq 
0.01%
Income Statement
